Skip to collection list Skip to video grid

Videos

Skip to collection list Skip to video grid

Pharmaceutical

Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

Dr. Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS. She then presents 3 examples of when LC-MS is the preferred method for quantification of insulin analogs and more.

Learn more
Read More
Read Less

categories

View more in
Pharmaceutical

Currently loaded videos are 16 through 30 of 69 total videos.

Load Previous Page Load Next Page
Sort By:
Sort By: Most Recent
2:35
Why nominate? An interview with the 2019 BioAnalysis Rising Star award winner.
Why nominate? An interview with the 2019 BioAnalysis Rising Star award winner.
4:45
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 6 of 6
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 6 of 6
5:04
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 5 of 6
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 5 of 6
3:21
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 4 of 6
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 4 of 6
1:01:33
Webinar | Introduction to Analytical Procedure (Method) Lifecycle Management
Webinar | Introduction to Analytical Procedure (Method) Lifecycle Management
5:45
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 3 of 6
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 3 of 6
6:20
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 2 of 6
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 2 of 6
2:32
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 1 of 6
Navigating Challenges Associated with Bioanalysis of Therapeutic and Endogenous Peptides | Part 1 of 6
43:13
WEBINAR | Improving Analytical Method Performance Through Quality Risk Management and a Design of Experiments Approach
WEBINAR | Improving Analytical Method Performance Through Quality Risk Management and a Design of Experiments Approach
7:00
High-throughput, Batch-processing Metabolite Identification
High-throughput, Batch-processing Metabolite Identification
7:13
Improved Spectral Clarity with DIA Methods for Stuctural Elucidation Using CCS Values in Drug Discovery
Improved Spectral Clarity with DIA Methods for Stuctural Elucidation Using CCS Values in Drug Discovery
8:23
Comprehensive, Data Compliant Metabolite Identification using the UNIFI Met ID Application
Comprehensive, Data Compliant Metabolite Identification using the UNIFI Met ID Application
8:14
Using Collision Cross Section (CCS) Values to Identify and Track Metabolites in Drug Development
Using Collision Cross Section (CCS) Values to Identify and Track Metabolites in Drug Development
58:15
Taking Advantage of Ion Mobility Enabled Approaches for Discovery Metabolite Identification
Taking Advantage of Ion Mobility Enabled Approaches for Discovery Metabolite Identification
13:29
High Resolution Mass Spectrometry for Quantification of Intact Monoclonal Antibodies in Plasma
High Resolution Mass Spectrometry for Quantification of Intact Monoclonal Antibodies in Plasma

Currently loaded videos are 16 through 30 of 69 total videos.

Load Previous Page Load Next Page

© 2023 Waters Corporation. All Rights Reserved.